GRACE

cancergrace.org

 

GRACE
Avatar

2020 ASCO ADAURA Trial Update on Adjuvant Osimertinib in EGFR+ NSCLC: What Is the Clinical Impact? Should We Be Concerned About the Lack of OS Data?

By GRACE FEATURING Helena Yu, David Spigel, Jack West
By GRACE FEATURING Helena Yu, David Spigel, Jack West
195 views
December 1, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

Making the First Chance Count: Manuel

Feat. A. Ip

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Lung
17:13

New

Case-Based Panel: Managing EGFR Exon 21 L858R mNSCLC and Insights Fr…

GRACE

A. Saxena, E. Singhi, I. Preeshagul, N. Rohs

19 views
17:43

New

Case-Based Panel: Treating 70 y/o Female With SCLC and Insights From…

GRACE

E. Singhi, N. Rohs, A. Saxena, I. Preeshagul

88 views
18:45

New

Case-Based Panel: Managing EGFR Exon 19 Lung Cancer and Insights Fro…

GRACE

N. Rohs, A. Saxena, E. Singhi, I. Preeshagul

60 views
04:46

Repeat Biopsy in KRAS+ NSCLC

GRACE

J. Luo

82 views
05:27

Biopsies in Lung Cancer: Tumor vs. Liquid

GRACE

J. Luo

186 views
04:24

Treatment Strategies for KRAS+ NSCLC

GRACE

J. Luo

71 views
09:21

An Overview of KRAS+ NSCLC and Diagnostic Testing

GRACE

J. Luo

91 views
04:22

Targeted Therapy in Lung Cancer: Side Effects

GRACE

T. Patil

80 views
04:08

Targeted Therapy in Lung Cancer: The Importance of Biomarkers

GRACE

T. Patil

99 views
04:01

Lung Resection in Early Stage NSCLC: An Overview

GRACE

C. Jeffrey Yang

258 views
05:58

Future Goals of mNSCLC Treatment

GRACE

P. Iyengar

64 views
06:13

The NRG-LU Trial: Maintenance Systemic Therapy vs. Local Consolidati…

GRACE

P. Iyengar

54 views
06:14

Using Radiation to Improve Outcomes and QoL in Patients With mNSCLC

GRACE

P. Iyengar

9 views
02:41

Staging Disease: How Oncologists Stage NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

593 views
03:19

Biomarkers in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

198 views
06:09

Perioperative vs. Preoperative Surgery in NSCLC

GRACE

I. Dagogo-Jack, M. Das, C. Jeffrey Yang

408 views
03:25

Antibody Drug Conjugates and How They Are Used in NSCLC

GRACE

L. Bazhenova

31 views
02:36

ADC Treatment in NSCLC

GRACE

L. Bazhenova

22 views
03:15

Bispecific Antibodies in Lung Cancer

GRACE

L. Bazhenova

19 views
02:52

Amivantamab in 1L Advanced NSCLC With EGFR exon 20 Insertion Mutatio…

GRACE

L. Bazhenova

35 views
05:47

Treatment Options for EGFR+ NSCLC

GRACE

I. Dagogo-Jack, N. Vokes

33 views
03:42

Surgical Options for Stage IV NSCLC With Brain Metastases: 60 y/o Wo…

GRACE

I. Dagogo-Jack, J. Reuss

12 views
06:02

Neoadjuvant Chemo +/- Nivo for Patients With Early Stage NSCLC: Case…

GRACE

I. Dagogo-Jack, J. Reuss

89 views
03:21

Treating Stage III NSCLC: Case-Based Panel Discussion

GRACE

I. Dagogo-Jack, K. Arbour

21 views
03:44

How Oncologists Stage Disease - Case-Based Panel Discussion: 50 y/o …

GRACE

I. Dagogo-Jack, J. Reuss, N. Vokes, K. Arbour

20 views
09:37

Is Broad NGS the Standard of Care in Advanced NSCLC?

GRACE

I. Dagogo-Jack, M. Marmarelis, A. Sacher, A. Hegde

133 views
05:27

Neoadjuvant Therapy vs. Adjuvant Therapy in NSCLC: What Is the Futur…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

102 views
05:38

Surgical vs. Nonsurgical Treatment in Early NSCLC

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

89 views
07:28

Early Stage NSCLC: PD-L1 and Durvalumab

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

85 views
04:35

Testing in Potentially Resectable & Unresectable Locally Advanced NS…

GRACE

J. West, E. Rodriguez, R. Shah, N. Duma

96 views
22:49

The Need for Broad Molecular Testing for Driver Mutations in NSCLC

GRACE

J. Gainor

107 views
26:08

NSCLC Frontline Therapy for Uncommon Mutations: Overview of RET, NTR…

GRACE

J. Gainor

108 views
06:15

Expert Discussion on Targeted Therapy for mNSCLC: Can ALK Inhibitors…

GRACE

J. West

38 views
18:10

A Case of a NSCLC KRAS 71 y/o Female With Underlying Autoimmune Cond…

GRACE

S. Liu, J. Brahmer, B. Levy

76 views
15:42

Expert Analysis of 1L EGFR+ Advanced NSCLC Options: 1st Gen Gefitini…

GRACE

J. Weiss

205 views
10:33

Targeted Therapy for EGFR+ NSCLC: How Do We Think About Acquired Res…

GRACE

Z. Piotrowska

114 views
18:15

Targeted Therapy for EGFR+ NSCLC: What Are the Current Options Upon …

GRACE

Z. Piotrowska

104 views
05:41

ASCO Expert Discussion on Malignant Pleural Mesothelioma: Does Durva…

GRACE

J. West, H. Yu, D. Spigel

29 views
05:47

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

GRACE

J. West, H. Yu, D. Spigel

103 views
10:25

IO for Unresectable Stage 3 NSCLC: Does Durvalumab Help Patients? Wh…

GRACE

M. Das

66 views
08:13

2020 ASCO Highlights on RT+ Chemo in LS-SCLC: Is There a Difference …

GRACE

J. West, H. Yu, D. Spigel

63 views
16:22

2020 ASCO ADAURA Trial Update on Adjuvant Osimertinib in EGFR+ NSCLC…

GRACE

H. Yu, D. Spigel, J. West

195 views
11:28

2020 ASCO Update on 1L Advanced NSCLC: Is Nivo + Ipi + Limited Cours…

GRACE

H. Yu, D. Spigel, J. West

110 views
11:22

2020 ASCO Update on Advanced NSCLC: What Is the Role for Nivolumab/I…

GRACE

H. Yu, D. Spigel, J. West

129 views
09:02

2020 ASCO Update on MET/RET+ NSCLC: How Promising Are Capmatinib & P…

GRACE

H. Yu, D. Spigel, J. West

119 views
08:25

2020 ASCO Update on HER2+ NSCLC: Is There a Promising Clinical Activ…

GRACE

H. Yu, D. Spigel, J. West

19 views
12:16

2020 ASCO Update on EGFR+ NSCLC: Does Upfront SBRT to Sites at Diagn…

GRACE

H. Yu, D. Spigel, J. West

571 views
08:16

ASCO 2020 Updates on PD-L1 NSCLC: Is Tiragolumab+Atezo Beneficial fo…

GRACE

J. West, H. Yu, D. Spigel

77 views
05:32

2020 Updates on SCLC: Have We Progressed in the Treatment of Relapse…

GRACE

T. Owonikoko

226 views
05:16

Liquid Biopsy in NSCLC: Does Adding Liquid Biopsy to Tissue Testing …

GRACE

C. Aggarwal

267 views
06:45

SCLC Updates: What Are the Leading Immunotherapy Options?

GRACE

S. Liu

314 views
05:38

Expert Discussion on mNSCLC: What Are the Leading Treatment Options …

GRACE

S. Liu

340 views
05:45

2020 Update on Molecular Abnormalities in NSCLC: How Do MET Exon 14 …

GRACE

J. Bauml

248 views
05:56

The Role of IO for NSCLC Patients With Driver Mutations: What Data D…

GRACE

B. Levy

192 views
07:43

2020 Update on Targeted Therapies in NSCLC PD-L1 Expression: What Ar…

GRACE

M. Das

112 views
07:55

Non-Small Cell Lung Cancer: Is Immunotherapy Safe for Frail Patients…

GRACE

M. Gubens

55 views
05:13

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

GRACE

M. Das

207 views
06:15

Non-Small Cell Lung Cancer: How Does a Positive HER2 Mutation Affect…

GRACE

J. West, J. Riess, S. Padda

18 views
06:03

ALK+ NSCLC With High PD-L1. What Is the First Line Treatment for Pot…

GRACE

J. West, J. Riess, S. Padda

137 views
06:00

What Is the Importance of MET Amplification Level in EGFR+ NSCLC Wit…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
03:45

NSCLC EGFR Mutation Treated With Tagrisso: Progression While on Trea…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
07:30

NSCLC EGFR Mutation and the FLAURA Trial: Is There a Difference in D…

GRACE

C. McCoach, H. Wakelee, J. West

15 views
08:20

EGFR + NSCLC: Is There a Place for Chemo and the Inclusion of Immuno…

GRACE

J. West, H. Wakelee, C. McCoach

746 views
04:14

EGFR Mutation and High and High PD-L1 in NSCLC: What is the Role of …

GRACE

C. McCoach, H. Wakelee, J. West

16 views
05:18

Non-Small Cell Lung Cancer: What Are the Recommended Treatments for …

GRACE

C. McCoach, H. Wakelee, J. West

123 views
05:04

NSCLC With EGFR Mutation: What Are the Treatment Options with Oligop…

GRACE

C. McCoach, H. Wakelee, J. West

11 views
07:12

NSCLC With EGFR Mutation: Is There a Place for Chemotherapy and an E…

GRACE

C. McCoach, H. Wakelee, J. West

525 views
05:52

NSCLC With EGFR Uncommon Exon 20 Mutation: Suggested Treatments, Tar…

GRACE

C. McCoach, H. Wakelee, J. West

20 views
04:20

The Challenges of Potential Pneumonitis Following Durvalumab in Stag…

GRACE

M. Gubens, J. West, M. Das

18 views
06:03

Would IO Be Beneficial for Stage 3 NSCLC Patient with PDL1-0 After S…

GRACE

M. Gubens, J. West, M. Das

135 views
08:02

Best Schedule for Durvalumab for Older Patient in Stage 3 NSCLC Afte…

GRACE

J. West, M. Gubens, M. Das

235 views
05:12

Unresectable NSCLC: What Is TMB and Does it Add Significant Benefit …

GRACE

M. Gubens, J. West, M. Das

470 views
08:50

Does Checkmate 227's Suggestion of an IO Combination of Ipi + Nivo O…

GRACE

M. Gubens, J. West, M. Das

131 views
10:58

Should Molecular Tests Be Considered in Stage 3 NSCLC and Would Outc…

GRACE

M. Gubens, J. West, M. Das

323 views
09:22

Case of 60 y/o Woman with ALK Positive Metastatic NSCLC: Approach to…

GRACE

S. Padda, J. Riess, J. West

197 views
06:14

Case of ALK Positive Patient with Asymptomatic Brain Metastases: Is …

GRACE

S. Padda, J. Riess, J. West

17 views
09:45

Treatment for NSCLC Patient Who Developed Resistance to ALK Inhibito…

GRACE

S. Padda, J. Riess, J. West

18 views
11:11

Is the Standard Treatment the Best Approach for Stage 3 Frail Patien…

GRACE

M. Gubens, J. West, M. Das

396 views
06:43

Should We Continue the ALK Inhibitor in NSCLC Patient with Brain Met…

GRACE

S. Padda, J. Riess, J. West

126 views
10:53

Is There a Role for Combination Therapies Like Chemo/Radio and IO fo…

GRACE

S. Padda, J. Riess, J. West

337 views
09:53

Stage 3 NSCLC - Standard Concurrent Chemo + Radiation, Followed by I…

GRACE

M. Gubens, J. West, M. Das

176 views
11:27

Stage 3 NSCLC: Is the Standard Treatment of Chemo and Radiation Foll…

GRACE

M. Gubens, J. West, M. Das

281 views
11:26

Case Based Discussion on Stage 3 NSCLC: Should We Do Molecular Tests…

GRACE

M. Gubens, J. West, M. Das

347 views
05:24

CancerGRACE's ASCO 2019 Update on Lung Cancer: How Promising is Lurb…

GRACE

J. West, B. Levy, C. Aggarwal

877 views
05:32

CancerGRACE's ASCO 2019 Update on Lung Cancer: Short Discussion on K…

GRACE

J. West, B. Levy, C. Aggarwal

178 views
06:02

CancerGRACE's ASCO 2019 Update on Lung Cancer: Circulating Tumor DNA…

GRACE

J. West, B. Levy, C. Aggarwal

95 views
05:53

CancerGRACE's ASCO 2019 Update on Lung Cancer: Retrospective Analysi…

GRACE

J. West, B. Levy, C. Aggarwal

99 views
03:55

CancerGRACE's ASCO 2019 Update on Stage IV NSCLC: New Targets - RET

GRACE

J. West, B. Levy, C. Aggarwal

148 views
06:33

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

283 views
07:14

CancerGRACE's ASCO 2019 Highlights and New Approaches in Stage IV NS…

GRACE

J. West, B. Levy, C. Aggarwal

69 views
06:33

CancerGRACE's 2019 ASCO Highlights in Advanced NSCLC: What is the Lo…

GRACE

J. West, B. Levy, C. Aggarwal

224 views
06:38

CancerGRACE's 2019 ASCO Highlights on Adjuvant Afatinib in Stage II …

GRACE

J. West, B. Levy, C. Aggarwal

470 views
07:26

CancerGRACE's 2019 ASCO Highlights on Stage I NSCLC Adjuvant Chemoth…

GRACE

J. West, B. Levy, C. Aggarwal

25 views
21:24

Is There a Role for IO in EGFR+ Metastatic Lung Cancer?

GRACE

H. Yu

4.8K views
47:56

Initial Treatment and Acquired Resistance in Advanced Lung Cancer & …

GRACE

J. Bauml, J. Sabari

208 views
21:58

Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

J. Bauml

15 views
19:19

Introduction to Next Generation Sequencing in Metastatic Lung Cancer…

GRACE

J. Bauml

626 views
23:26

EGFR Initial Treatment and Acquired Resistance in Advanced NSCLC

GRACE

H. Yu

179 views
09:30

Q&A on EGFR Initial Treatment and Acquired Resistance in Advanced NS…

GRACE

H. Yu

33 views
07:53

Optimal First Line Treatment of EGFR+ Advanced NSCLC: First and Seco…

GRACE

J. West

113 views
18:32

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Osimertinib vs…

GRACE

J. West

558 views
17:04

Optimal First Line Treatment of EGFR+ Advanced NSCLC: Dacomitinib, E…

GRACE

J. West

676 views
17:10

Targeted Therapies in Advanced Lung Cancer: What is the Role of Rebi…

GRACE

H. Borghaei

462 views
26:54

Discussion/Q&A on Targeted Therapies in Advanced Lung Cancer

GRACE

H. Borghaei

24 views
15:23

Targeted Therapies in Metastatic NSCLC: Liquid Biopsies as a New Opt…

GRACE

C. Aggarwal

623 views
02:13

Immunotherapy in Stage lll NSCLC - The Pacific Trial and Imfinzi

GRACE

K. Kelly

167 views
01:54

Tumor Mutation Burden in Patients with Non-Squamous NSCLC: Current S…

GRACE

S. Patel

20 views
02:41

Evolving Standards for Molecular Testing in Advanced NSCLC

GRACE

S. Patel

21 views
02:05

Combinations of Immunotherapy Agents in Advanced NSCLC: Current Stat…

GRACE

S. Patel

18 views
02:17

The Basics of Managing Immune-Mediated Side Effects in NSCLC

GRACE

S. Patel

24 views
03:50

What Should Patients With Rapid Progression in Advanced NSCLC Throug…

GRACE

J. West

190 views
04:46

"Consolidation" Radiation After a Good Response to First Line Therap…

GRACE

J. West

14 views
06:57

Chemotherapy and Immunotherapy Combinations in Advanced Non-Squamous…

GRACE

J. West

164 views
05:39

Chemo Immuno Therapy Combinations in Advanced Squamous NSCLC

GRACE

J. West

179 views
07:13

Does Immunotherapy Work in Patients with Driver Mutations Like EGFR …

GRACE

J. West

237 views
04:09

EGFR TKI Gilotrif(Afatinib) in Metastatic Squamous NSCLC

GRACE

V. Velcheti

201 views
04:24

Lung Cancer Immunotherapy- Is There Anything Better than PDL1

GRACE

V. Velcheti

114 views
03:20

MET as a Target in Advanced NSCLC

GRACE

V. Velcheti

24 views
04:33

The Changing Landscape of 1L Treatment of ALK-Positive Advanced NSCL…

GRACE

A. Shaw

45 views
06:02

Patterns of Resistance in ALK Positive NSCLC

GRACE

A. Shaw

227 views
05:04

Controlling Brain Metastases in Patients with Molecular Driven Advan…

GRACE

A. Shaw

30 views
02:14

Immunotherapy for Previously Treated Patients with NSCLC

GRACE

K. Reckamp

16 views
04:50

New Options in Acquired Resistance for ALK+ Metastatic Non-small Cel…

GRACE

N. Pennell

235 views
03:45

The Role for Immunotherapy in Patients with a Driver Mutation Lung C…

GRACE

N. Pennell

19 views
03:35

Liquid Biopsies for Broad Genomic Testing in Lung Cancer

GRACE

N. Pennell

31 views
03:53

Liquid Biopsies for EGFR T790M Advanced NSCLC

GRACE

N. Pennell

17 views
02:45

The Role of Angiogenesis in Previously Treated NSCLC

GRACE

K. Reckamp

16 views
09:07

Advanced Non Squamous NSCLC, High PD-L1, No Mutation - Optimal 1st L…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

219 views
12:59

Advanced Non Squamous NSCLC, Low PD-L1, No Mutation - Best Systemic …

GRACE

J. West, Z. Piotrowska, T. Owonikoko

236 views
11:09

Case Based Panel Discussion - Fit Patient Adv Squamous NSCLC Low Tum…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

15 views
08:18

Lung Cancer Case Based Panel Discussion - EGFR and High PDL-1, Choos…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

150 views
09:21

Case Based Panel Discussions - Metastatic Squamous NSCLC Low Tumor P…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

15 views
08:17

Rapid Progression Lung Adenocarcinoma High PD-L1 - How Do You Treat?…

GRACE

J. West, Z. Piotrowska, T. Owonikoko

65 views
11:15

ASCO 2018 - Keynote 042 - Keytruda as a Single Agent Compared to Dou…

GRACE

K. Kelly, J. West, S. Patel

353 views
12:26

ASCO 2018 - Potential Showdown of Two Positive Trials? Keynote 407 a…

GRACE

K. Kelly, J. West, S. Patel

21 views
11:29

ASCO 2018 Keynote189 - Cisplatin or Carboplatin with Alimta & Keytru…

GRACE

K. Kelly, J. West, S. Patel

19 views
09:40

ASCO 2018 - Checkmate 227 - Combinations of Nivolumab and Ipilimumab…

GRACE

K. Kelly, J. West, S. Patel

21 views
07:35

ASCO 2018 - Will Taking Mod to High Dose Steroids Affect Lung Cancer…

GRACE

K. Kelly, J. West, S. Patel

14 views
09:11

ASCO 2018 - Tarceva or Tarceva with Avastin as 1st Line for EGFR Pos…

GRACE

K. Kelly, J. West, S. Patel

13 views
06:27

ASCO 2018 - Tarceva Combined with Carboplatin & Alimta - Given Upfro…

GRACE

K. Kelly, J. West, S. Patel

18 views
02:52

ASCO 2018 - Combining Metformin with Standard EGFR Therapy - Is the …

GRACE

K. Kelly, J. West, S. Patel

17 views
03:34

ASCO 2018 - Keynote 158 - Keytruda in Previously Treated, Now Relaps…

GRACE

K. Kelly, J. West, S. Patel

18 views
04:26

ASCO 2018 - Dream Study - Chemo with Imfinzi (durvalumab) for Mesoth…

GRACE

K. Kelly, J. West, S. Patel

28 views
25:01

OncTalk 2018 - Newer Technologies in Radiation - Local Therapies for…

GRACE

V. Mehta

17 views
21:07

OncTalk 2018 - Novel Indications for Local Therapy in Adv NSCLC - Lo…

GRACE

P. Iyengar

8 views
19:01

NSCLC - Local Therapies for Metastatic LC

GRACE

E. Vallieres

200 views
27:13

OncTalk 2018 - Systemic Therapies for Advanced NSCLC - Local Therapi…

GRACE

J. West

19 views
45:31

OncTalk 2018 - Panel Discussion and Q&A - Local Therapies for Metast…

GRACE

E. Vallieres, J. West, V. Mehta, P. Iyengar

16 views